Specific VpU codon changes were significantly associated with gp120 V3 tropic signatures in HIV-1 B-subtype

Virologica Sinica

Volumn 27, Issue 6, 2012, Pages 360-368

  Dimonte, Salvatore ^a   Babakir Mina, Muhammed ^a,b   Aquaro, Stefano ^c   Perno, Carlo Federico ^a,d  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b Iraqi Kurdistan Region   (Italy)

^c UNIVERSITY OF CALABRIA   (Italy)

^d NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

Author keywords

Cluster analysis; gp120 V3; HIV; Mutations; Tropism; VpU

Indexed keywords

CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; GLYCOPROTEIN GP 120; UNCLASSIFIED DRUG; V3 PROTEIN; VIRUS PROTEIN; VPU PROTEIN;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ARTICLE; CLUSTER ANALYSIS; CODON; CONTROLLED STUDY; GENE CLUSTER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PHI COEFFICIENT; PROTEIN DOMAIN; STATISTICAL ANALYSIS; VIRAL TROPISM; VIRUS MUTATION; VPU GENE;

AMINO ACID SUBSTITUTION; CODON; HIV ENVELOPE PROTEIN GP120; HIV-1; HUMAN IMMUNODEFICIENCY VIRUS PROTEINS; HUMANS; MUTATION RATE; MUTATION, MISSENSE; RECEPTORS, HIV; VIRAL REGULATORY AND ACCESSORY PROTEINS; VIRAL TROPISM;

EID: 84875168759     PISSN: 16740769     EISSN: 1995820X     Source Type: Journal    
DOI: 10.1007/s12250-012-3287-0     Document Type: Article

References (45)

1. Althaus C F, Vongrad V, Niederost B, et al. 2012. Tailored enrichment strategy detects low abundant small noncoding RNAs in HIV-1 infected cells. Retrovirology, 9: 27.
2. Benjamini Y, Hochberg Y. 1995. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc B, 57: 289-300.
3. Binette J, Cohen E A. 2004. Recent advances in the understanding of HIV-1 Vpu accessory protein functions. Curr Drug Targets Immune Endocr Metabol Disord, 4: 297-307. (Pubitemid 39445427)
4. Casella C R, Rapaport E L, Finkel T H. 1999. Vpu increases susceptibility of human immunodeficiency virus type 1-infected cells to fas killing. J Virol, 73: 92-100. (Pubitemid 28565350)
5. Cashin K, Roche M, Sterjovski J, et al. 2011. Alternative coreceptor requirements for efficient. J Virol, 85: 10699-10709.
6. Chen M Y, Maldarelli F, Karczewski M K, et al. 1993. Human immunodeficiency virus type 1 Vpu protein induces degradation of CD4 in vitro: the cytoplasmic domain of CD4 contributes to Vpu sensitivity. J Virol, 67: 3877-3884. (Pubitemid 23180710)
7. Cohen E A, Terwilliger E F, Sodroski J G, et al. 1988. Identification of a protein encoded by the vpu gene of HIV-1. Nature, 334: 532-534.
8. D'Agostino D M, Felber B K, Harrison J E, et al. 1992. The Rev protein of human immunodeficiency virus type 1 promotes polysomal association and translation of gag/pol and vpu/env mRNAs. Mol Cell Biol, 12: 1375-1386.
9. de Jong J J, de Ronde A, Keulen W, et al. 1992. Minimal requirements for the human immunodeficiency virus type 1 V3 domain to support the syncytium-inducing phenotype: analysis by single amino acid substitution. J Virol, 66: 6777-6780.
10. Dejucq N, Simmons G, Clapham P R. 2000. T-cell line adaptation of human immunodeficiency virus type 1 strain SF162: effects on envelope, vpu and macrophage-tropism. J Gen Virol, 81: 2899-2904. (Pubitemid 32000637)
11. V3 signatures in the regulation of co-receptor usage. Retrovirology, 8: 33.
12. Dimonte S, Mercurio F, Svicher V, et al. 2012. Genetic and Structural Analysis of HIV-1 Rev Responsive Element Related to V38A and T18A Enfuvirtide Resistance Mutations. Intervirology, 55: 385-390.
13. C2-V3-C3 mutations and their association with CCR5 and CXCR4 tropism. Arch Virol, 156: 1943-1951.
14. Dube M, Bego M G, Paquay C, et al. 2010. Modulation of HIV-1-host interaction: role of the Vpu accessory protein. Retrovirology, 7: 114.
15. Fouchier R A, Groenink M, Kootstra N A, et al. 1992. Phenotype-associated sequence variation in the third variable domain of the human immunodeficiency virus type 1 gp120 molecule. J Virol, 66: 3183-3187.
16. Fujita K, Omura S, Silver J. 1997. Rapid degradation of CD4 in cells expressing human immunodeficiency virus type 1 Env and Vpu is blocked by proteasome inhibitors. J Gen Virol, 78(Pt 3): 619-625. (Pubitemid 27116783)
17. Ghaffari G, Tuttle D L, Briggs D, et al. 2005. Complex determinants in human immunodeficiency virus type 1 envelope gp120 mediate CXCR4-dependent infection of macrophages. J Virol, 79: 13250-13261. (Pubitemid 41508140)
18. Gottlinger H G, Dorfman T, Cohen E A, et al. 1993. Vpu protein of human immunodeficiency virus type 1 enhances the release of capsids produced by gag gene constructs of widely divergent retroviruses. Proc Natl Acad Sci U S A, 90: 7381-7385. (Pubitemid 23222454)
19. Hout D R, Gomez L M, Pacyniak E, et al. 2006. A single amino acid substitution within the transmembrane domain of the human immunodeficiency virus type 1 Vpu protein renders simian-human immunodeficiency virus (SHIV(KU-1bMC33)) susceptible to rimantadine. Virology, 348: 449-461.
20. Huang C C, Lam S N, Acharya P, et al. 2007. Structures of the CCR5 N terminus and of a tyrosine-sulfated antibody with HIV-1 gp120 and CD4. Science, 317: 1930-1934. (Pubitemid 47509439)
21. Hussain A, Das S R, Tanwar C, et al. 2007. Oligomerization of the human immunodeficiency virus type 1 (HIV-1) Vpu protein - a genetic, biochemical and biophysical analysis. Virol J, 4: 81. (Pubitemid 350012305)
22. Iwatani Y, Song S K, Wang L, et al. 1997. Human immunodeficiency virus type 1 Vpu modifies viral cytopathic effect through augmented virus release. J Gen Virol, 78(Pt 4): 841-846. (Pubitemid 27179750)
23. Jiang C, Parrish N F, Wilen C B, et al. 2011. Primary infection by a human immunodeficiency virus with atypical coreceptor tropism. J Virol, 85: 10669-10681.
24. Karn J, Stoltzfus C M. 2012. Transcriptional and Posttranscriptional Regulation of HIV-1 Gene Expression. Cold Spring Harb Perspect Med, 2: a006916.
25. Kawamura M, Ishizaki T, Ishimoto A, et al. 1994. Growth ability of human immunodeficiency virus type 1 auxiliary gene mutants in primary blood macrophage cultures. J Gen Virol, 75(Pt 9): 2427-2431. (Pubitemid 24282260)
26. Krummheuer J, Johnson A T, Hauber I, et al. 2007. A minimal uORF within the HIV-1 vpu leader allows efficient translation initiation at the downstream env AUG. Virology, 363: 261-271. (Pubitemid 46764948)
27. Magadan J G, Bonifacino J S. 2012. Transmembrane domain determinants of CD4 Downregulation by HIV-1 Vpu. J Virol, 86: 757-772.
28. Marchal C, Vinatier G, Sanial M, et al. 2012. The HIV-1 Vpu Protein Induces Apoptosis in Drosophila via Activation of JNK Signaling. PLoS One, 7: e34310.
29. Margottin F, Benichou S, Durand H, et al. 1996. Interaction between the cytoplasmic domains of HIV-1 Vpu and CD4: role of Vpu residues involved in CD4 interaction and in vitro CD4 degradation. Virology, 223: 381-386. (Pubitemid 26319600)
30. Michalski C J, Li Y, Kang C Y. 2010. Induction of cytopathic effects and apoptosis in Spodoptera frugiperda cells by the HIV-1 Env glycoprotein signal peptide. Virus Genes, 41: 341-350.
31. Park S H, Opella S J. 2007. Conformational changes induced by a single amino acid substitution in the trans-membrane domain of Vpu: implications for HIV-1 susceptibility to channel blocking drugs. Protein Sci, 16: 2205-2215. (Pubitemid 47481655)
32. Peterlin B M, Trono D. 2003. Hide, shield and strike back: how HIV-infected cells avoid immune eradication. Nat Rev Immunol, 3: 97-107. (Pubitemid 37328688)
33. Richards K H, Clapham P R. 2007. Effects of vpu start-codon mutations on human immunodeficiency virus type 1 replication in macrophages. J Gen Virol, 88: 2780-2792. (Pubitemid 47555033)
34. Schubert U, Clouse K A, Strebel K. 1995. Augmentation of virus secretion by the human immunodeficiency virus type 1 Vpu protein is cell type independent and occurs in cultured human primary macrophages and lymphocytes. J Virol, 69: 7699-7711.
35. Schubert U, Henklein P, Boldyreff B, et al. 1994. The human immunodeficiency virus type 1 encoded Vpu protein is phosphorylated by casein kinase-2 (CK-2) at positions Ser52 and Ser56 within a predicted alpha-helix-turn-alpha-helix-motif. J Mol Biol, 236: 16-25. (Pubitemid 24148943)
36. Schwartz S, Felber B K, Pavlakis G N. 1992. Mechanism of translation of monocistronic and multicistronic human immunodeficiency virus type 1 mRNAs. Mol Cell Biol, 12: 207-219.
37. Shibata R, Hoggan M D, Broscius C, et al. 1995. Isolation and characterization of a syncytium-inducing, macrophage/T-cell line-tropic human immunodeficiency virus type 1 isolate that readily infects chimpanzee cells in vitro and in vivo. J Virol, 69: 4453-4462.
38. Stephens E B, McCormick C, Pacyniak E, et al. 2002. Deletion of the vpu sequences prior to the env in a simian-human immunodeficiency virus results in enhanced Env precursor synthesis but is less pathogenic for pig-tailed macaques. Virology, 293: 252-261.
39. Strebel K, Klimkait T, Martin M A. 1988. A novel gene of HIV-1, vpu, and its 16-kilodalton product. Science, 241: 1221-1223.
40. Svicher V, Alteri C, D'Arrigo R, et al. 2009. Treatment with the fusion inhibitor enfuvirtide influences the appearance of mutations in the human immunodeficiency virus type 1 regulatory protein rev. Antimicrob Agents Chemother, 53: 2816-2823.
41. th Conference on Retroviruses and Opportunistic Infections; February 16-19, 2010; San Francisco, CA (http://retroconference.org/2010/Abstracts/38958.htm)
42. Taylor W R. 1986. The classification of amino acid conservation. J Theor Biol, 119: 205-218. (Pubitemid 16111664)
43. Verma S, Ali A, Arora S, et al. 2011. Inhibition of beta-TrcP-dependent ubiquitination of p53 by HIV-1 Vpu promotes p53-mediated apoptosis in human T cells. Blood, 117: 6600-6607.
44. Waheed A A, Freed E O. 2010. The Role of Lipids in Retrovirus Replication. Viruses, 2: 1146-1180.
45. Wilen C B, Tilton J C, Doms R W. 2012. Molecular mechanisms of HIV entry. Adv Exp Med Biol, 726: 223-242.